Twist Bioscience Corp — Director's Dealing 2018

Oct 30, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2018-10-30

Reporting Person: THORBURN JAMES M (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$11.59	2028-06-06	Common Stock (176749)		Direct

Footnotes

F1: The option is immediately exercisable. 25% of the shares subject to the option vest on April 23, 2019, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.